Home›Companies›Biotech & Pharma›Judo Bio

Judo Bio Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 16, 2024·Suggest an edit

About Judo Bio

Judo Bio is a private company based in Cambridge, Massachusetts, incorporated in 2021 in Delaware. It has reported $55,000,000 raised in three offerings on Form D since November 2022.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 31, 2024Aug 16, 2024$25,000,000target not set21$1.1MEquityRule 506(b)Form D ↗
May 17, 2024Jun 3, 2024$5,000,000fully sold2$2.5MDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Nov 4, 2022Nov 22, 2022amended Nov 21, 2023$25,000,000target not set2$12.5MEquityRule 506(b)Form D/A ↗1 earlier filing
Total, three offerings$55,000,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Judo Bio's Form D filed Aug 16, 2024.

OC
Ommer Chohan
Executive officer
AM
JG
James Goater
Executive officer and director
KB
Kevin Bitterman
President and director
SB
Sam Bjork
Director

Earlier filings also listed Hui Tian (director, last listed Jun 2024) and Chelsea Johnson (director, last listed Jun 2024).

Sources

  1. SECJudo Bio Inc. Form D, filed Nov 22, 2022
  2. SECJudo Bio Inc. filing history